Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, GKB Ophthalmics's Enterprise Value is ₹377 Mil.
GKB Ophthalmics's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹58 Mil. Therefore, GKB Ophthalmics's EV-to-EBIT ratio for today is 6.52.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, GKB Ophthalmics's Enterprise Value is ₹377 Mil.
GKB Ophthalmics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹90 Mil. Therefore, GKB Ophthalmics's EV-to-EBITDA ratio for today is 4.18.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, GKB Ophthalmics's Enterprise Value is ₹377 Mil.
GKB Ophthalmics's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,491 Mil. Therefore, GKB Ophthalmics's EV-to-Revenue ratio for today is 0.25.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
GKB Ophthalmics (BOM:533212) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
GKB Ophthalmics's current Enterprise Value is ₹377 Mil.
GKB Ophthalmics's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹58 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
GKB Ophthalmics's current Enterprise Value is ₹377 Mil.
GKB Ophthalmics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹90 Mil.
GKB Ophthalmics's current Enterprise Value is ₹377 Mil.
GKB Ophthalmics's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,491 Mil.
GKB Ophthalmics's current Enterprise Value is ₹377 Mil.
GKB Ophthalmics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
GKB Ophthalmics's current Enterprise Value is ₹377 Mil.
GKB Ophthalmics's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics Enterprise Value Related Terms
GKB Ophthalmics Enterprise Value Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Enterprise Value Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Enterprise Value distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
GKB Ophthalmics's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GKB Ophthalmics (BOM:533212) has a Enterprise Value of ₹377 Mil as of Jul. 21, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Enterprise Value too high?
GKB Ophthalmics' current Enterprise Value is ₹377 Mil. Overall, GKB Ophthalmics has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Enterprise Value compare to ISRG and BDX?
GKB Ophthalmics' Enterprise Value of ₹377 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Enterprise Value is ₹377 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Possible Value Trap. The stock's GF Value™ is ₹162.30, compared to a current price of ₹59.46 — trading 63.4% below its estimated fair value. The current Enterprise Value is ₹377 Mil. GKB Ophthalmics' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Enterprise Value is ₹377 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹59.46 is trading 63.4% below its estimated GF Value™ of ₹162.30.
GuruFocus considers GKB Ophthalmics to be Possible Value Trap.
Key valuation signals for BOM:533212:
Enterprise Value: ₹377 Mil
GF Value™: ₹162.30 vs. price of ₹59.46 (63.4% below fair value)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
63GF Score
Get the complete analysis for BOM:533212
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
